Reduced spontaneous relaxation in immature guinea pig airway smooth muscle is associated with increased prostanoid

Lu Wang1, Valeria Pozzato, Graziella Turato

  • 1Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

Insights

Infant guinea pig airway smooth muscle shows less relaxation due to higher prostanoid release. Cyclooxygenase-2 inhibition improves relaxation, suggesting prostanoids regulate airway function in young animals.

Area of Science:

  • Pulmonary Physiology
  • Pharmacology
  • Developmental Biology

Background:

  • Infant airway smooth muscle (ASM) exhibits reduced spontaneous relaxation compared to adult ASM.
  • Prostanoids, produced by cyclooxygenase (COX), are implicated in this age-related difference.
  • The specific roles of leukotrienes and COX isoforms in infant ASM relaxation require further investigation.

Purpose of the Study:

  • To determine if leukotrienes contribute to reduced spontaneous relaxation in infant ASM.
  • To investigate the differential roles of COX-1 and COX-2 in regulating ASM relaxation.
  • To examine the developmental regulation of prostanoid release in guinea pig ASM.

Main Methods:

  • Tracheal strips from different age groups of guinea pigs were used to measure relaxation.
  • Prostanoid release was quantified from tracheal segments.
  • Pharmacological agents including lipoxygenase inhibitor, cysteinyl leukotriene receptor-1 antagonist, COX-1 inhibitor, and COX-2 inhibitor were employed.

Main Results:

  • Inhibition of lipoxygenase or leukotriene receptor antagonism did not alter spontaneous relaxation.
  • Inhibition of COX-2, but not COX-1, significantly enhanced spontaneous relaxation.
  • Basal prostanoid release was higher in infant ASM and decreased with age, with thromboxane B2 being the predominant metabolite.

Conclusions:

  • Leukotrienes do not play a role in the reduced spontaneous relaxation of infant ASM.
  • COX-2-derived prostanoids contribute to diminished ASM relaxation in immature guinea pigs.
  • Elevated prostanoid levels in infant ASM may influence airway hyperresponsiveness in young animals.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation